One-Time DNA Study for Vasculitis

Part of paid clinical trials in Los Angeles, California.

Sponsor
University of Pennsylvania
Study ID
NCT01241305
Status
Recruiting

Conditions

  • Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss)
  • Giant Cell Arteritis
  • Granulomatosis With Polyangiitis (Wegener's)
  • Microscopic Polyangiitis
  • Polyarteritis Nodosa
  • Takayasu's Arteritis

Eligibility Criteria

Sex
ALL
Age
7 Years - N/A
Healthy Volunteers
Not accepted

Study Details

The purpose of this study is to identify genes that increase the risk of developing vasculitis, a group of severe diseases that feature inflammation of blood vessels. Results of these studies will provide vasculitis researchers with insight into the causes of these diseases and generate new ideas for diagnostic tests and therapies, and will be of great interest to the larger communities of researchers investigating vasculitis and other autoimmune, inflammatory, and vascular diseases.

Key Dates

Start date
Oct 31, 2010
Status verified
Jan 2026
Primary completion
Aug 31, 2028
Completion
Aug 31, 2028

Study Design

Enrollment
1,000 participants (estimated)

Primary Outcome Measure

Evaluation of clinical data and linked DNA specimens. [ Time Frame: 1 year. ]

Central Contacts

Locations (11)

FacilityCityStateZIPSite coordinators
Cedars-Sinai Medical CenterLos AngelesCalifornia90048-
University of California, San FranciscoSan FranciscoCalifornia94143-
Northwestern UniversityChicagoIllinois60208
John Seagrist
University of Kansas Medical CenterKansas CityKansas66103-
University of MichiganAnn ArborMichigan48109-5422-
Mayo ClinicRochesterMinnesota55905-
Hospital for Special SurgeryNew YorkNew York10021-
Cleveland ClinicClevelandOhio44195-
University of PennsylvaniaPhiladelphiaPennsylvania19104
Daniel Killion
Peter Merkel, MD, MPH (PRINCIPAL_INVESTIGATOR)
University of PittsburghPittsburghPennsylvania15261-
University of UtahSalt Lake CityUtah84132-

Find similar trials in Los Angeles, CA

Related Studies